HTL invests in GMP manufacturing capacity to support fast growing market of Hyaluronic Acid Medical Applications

by Business Wire • 2019/10/30 • 0 Comments

JAVENÉ, France--(BUSINESS WIRE)-- #hyaluronicacid--HTL Biotechnology invests in GMP manufacturing capacity to support the fast growing market of medical applications for Hyaluronic Acid.

Full Story →

← Riassunto: EMA e FDA accettano le richieste di autorizzazione alla commercializzazione per satralizumab nel trattamento del disturbo dello spettro della neuromielite ottica (NMOSD)

Aerie Pharmaceuticals to Announce Third Quarter 2019 Financial Results and Host Conference Call on Wednesday, November 6, 2019 →

Post navigation